MedPath

Feasibility Tests for Various Prism Configurations for Visual Field Loss

Not Applicable
Recruiting
Conditions
Hemianopia, Homonymous
Visual Field Defect, Peripheral
Visual Field Constriction Bilateral
Tunnel Vision
Visual Field Defect Homonymous Bilateral
Interventions
Device: High power prisms
Registration Number
NCT04424979
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Brief Summary

The investigators will develop and test different configurations of high-power prisms to expand the field of vision of patients with visual field loss to assist them with obstacle detection when walking. The study will involve multiple visits (typically four) to Schepens Eye Research Institute for fitting and testing with the prism glasses. The overall objective is to determine best designs and fitting parameters for implementation in prism devices for future clinical trials.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Visual field loss, either peripheral field loss or hemianopic field loss
  • Visual acuity of at least 20/50 in the better eye
  • In sufficiently good health to be able to complete sessions lasting 2-4 hours
  • Able to independently walk short distances
  • Able to give voluntary, informed consent
  • Able to speak English
Read More
Exclusion Criteria
  • Any physical or mental impairments, including cognitive dysfunction, balance problems or other deficits that could impair the ability to walk or use the prism spectacles
  • A history of seizures in the last 6 months
  • Hemispatial neglect (subjects with hemianopic field loss only)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
High power prismsHigh power prismsVarious configurations of high power prisms will be developed for each individual and custom fit into spectacles lenses.
Primary Outcome Measures
NameTimeMethod
Field of view expansionThrough study completion, an average of four months

Horizontal and vertical extent of the expansion (in degrees) of the field of view

Secondary Outcome Measures
NameTimeMethod
Pedestrian detection rateThrough study completion, an average of four months

Proportion of pedestrians detected (in simulated walking or simulated driving)

Trial Locations

Locations (1)

Schepens Eye Research Institute

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath